Ticker: ESPR

Company: Esperion Therapeutics, Inc.

Person: Benjamin Looker, officer

Transaction date: July 17, 2025

Reporting date: July 18, 2025

Average share price: 1.127

Sold 1304.0 shares for 1469.61